Trial Outcomes & Findings for Ultrafiltration in Pediatric Cardiac Surgery: An Observational Cohort Study (NCT NCT05154864)
NCT ID: NCT05154864
Last Updated: 2026-06-02
Results Overview
C3a
COMPLETED
40 participants
Sampled at the end of CPB
2026-06-02
Participant Flow
Recruitment occurred at the IWK Health Center in Halifax, Nova Scotia, between August 2020 and June 2021.
48 patients were screened, and 40 were eligible and consented to proceed with the study protocol. All 40 patients received the study treatment as specified.
Participant milestones
| Measure |
SBUF-SMUF
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Overall Study
STARTED
|
40
|
|
Overall Study
COMPLETED
|
40
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Ultrafiltration in Pediatric Cardiac Surgery: An Observational Cohort Study
Baseline characteristics by cohort
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Age, Categorical
<=18 years
|
40 Participants
n=9 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=9 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=9 Participants
|
|
Sex: Female, Male
Female
|
17 Participants
n=9 Participants
|
|
Sex: Female, Male
Male
|
23 Participants
n=9 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=9 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
40 Participants
n=9 Participants
|
PRIMARY outcome
Timeframe: Sampled at the end of CPBC3a
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Inflammatory Mediator C3a
|
30 pg/ml
Interval 24.1 to 36.5
|
PRIMARY outcome
Timeframe: Measured at the end of CPBOutcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Inflammatory Mediator C5a
|
106.4 pg/ml
Interval 56.2 to 192.6
|
PRIMARY outcome
Timeframe: Measured at the end of CPBOutcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Inflammatory Mediator IL-6
|
375.1 pg/ml
Interval 179.2 to 563.8
|
PRIMARY outcome
Timeframe: Measured at the end of CPBOutcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Inflammatory Mediator IL-8
|
63.7 pg/ml
Interval 31.3 to 108.7
|
SECONDARY outcome
Timeframe: Upon ICU AdmissionScale 0-60. Higher value resembles medical instability and a worse prognosis.
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Vasoactive-Ventilation-Renal Score
|
19 Units on a scale.
Interval 8.0 to 28.0
|
SECONDARY outcome
Timeframe: Upon ICU admissionScale 0-40. Higher value resembles medical instability and a worse prognosis.
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Vasoactive-Inotrope Score
|
7 Units on a scale.
Interval 2.0 to 10.0
|
SECONDARY outcome
Timeframe: Upon ICU AdmissionScale 0-40. Higher value resembles medical instability and a worse prognosis.
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Ventilation Index
|
11 Units on a scale.
Interval 0.0 to 19.0
|
SECONDARY outcome
Timeframe: Upon ICU admissionScale 0-20. Higher value resembles medical instability and a worse prognosis.
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Oxygenation Index
|
2 Units on a scale.
Interval 0.0 to 4.0
|
SECONDARY outcome
Timeframe: Upon ICU AdmissionTime on mechanical ventillator.
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Ventilation Time
|
19 hours
Interval 0.0 to 70.0
|
SECONDARY outcome
Timeframe: Through study completion, an average of 1 week.Standardized Discharge Criteria
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Intensive Care Unit Length of Stay
|
62 hours
Interval 24.0 to 95.0
|
SECONDARY outcome
Timeframe: Through study completion, an average of 1 week.Kidney Disease Improving Global Outcomes criteria with Stages 1-3
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Acute Kidney Injury
|
3 Participants with AKI.
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured through 24-hours post-operativeNumber
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Red Blood Cell Transfusion
|
0 ml/kg
Interval 0.0 to 13.6
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured through 24-hours post-operativenumber
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Plasma Transfusion
|
0 ml/kg
Interval 0.0 to 5.4
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Measured through 24-hours post-operativevolume in ml/kg
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Platelet Transfusion
|
0 ml/kg
Interval 0.0 to 5.2
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Through study completion, an average of 1 week.Volume in ml/kg
Outcome measures
| Measure |
SBUF-SMUF
n=40 Participants
All patients underwent standard of care cardiac surgery, cardiopulmonary bypass and SBUF-SMUF with effluent removal of 30 ml/kg/hr and physiologic solution replacement of 25ml/kg/hr.
|
|---|---|
|
Total Chest Tube Output
|
9 ml/kg
Interval 7.0 to 13.0
|
Adverse Events
SBUF-SMUF
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place